where Pyr means the group of formulas or where R1 - phenyl substituted with definite substituents; R1a - benzyl-group possibly substituted with Hal; RIV - H, Hal. (C1-C6)-alkyl; RV - phenyl-group substituted with definite substituents, or RV - naphthyl, pyridine or styrene substituted with (C1-C4)-alkyl, or RIV and RV taken together mean the group -2Ph-(CH2)i where phenyl-group substitutes pyrazole at 5 position and group (CH2)i where i = 1-3 substitutes pyrazole at position 4; R-H1(C1-C4)-alkyl; Z - -OH1(C1-C6)-alkoxy, amino; X and X1 - H or one of these is H and another is (C1-C6)-alkyl, (C3-C6)-cycloalkyl-(C1-C4)-alkyl, acetamido-(C1-C4)-alkylthiomethyl, guanidino-(C1-C4)-alkyl, carboxy-(C1-C4)-alkyl, nitroguanidino-(C1-C4)-alkyl, (C3-C7)-cycloalkyl, phenyl-(C1-C4)-alkyl possibly substituted with Hal, OH; heteroaryl-(C1-C4)-alkyl where heteroaryl - imidazolyl or indolyl, or X is H and X1 and R taken together form with nitrogen atoms the cycle of the formula (II) where m = 1-2, or indolinyl cycle, or 4,5,6,7-tetrahydro-[2,3-c]-thienopyridine cycle, or X and X1 where each means (C1-C4)-alkyl-(C3-C6)-cycloalkyl or phenyl, or X and X1 together with carbon atom form (C3-C12)-cycloalkylidene group that is substituted if necessary with (C1-C3)-alkyl, adamantylene, quinuclidinylidene, 4-piperidinylidene group which is possibly substituted with N-benzyl, tetrahydronaphthylidene, 4-tetrahydropyranyliedene, dihydro-2,3(4H)-4-benzothiopyranylidene, or dihydro-(4H)-4-benzopyranylidene group, or the group of the formulas a () and b (), or their salts with acids or bases and pharmaceutical composition based on the indicated compounds. ???EFFECT: improved method of synthesis."/> AMIDOPYRAZOLE DERIVATIVES OR THEIR SALTS WITH ORGANIC OR MINERAL ACIDS OR WITH ORGANIC OR INORGANIC BASES AND PHARMACEUTICAL COMPOSITION SHOWING INHIBITING ACTIVITY WITH RELATION TO NEUROTENSINE
首页> 外国专利> AMIDOPYRAZOLE DERIVATIVES OR THEIR SALTS WITH ORGANIC OR MINERAL ACIDS OR WITH ORGANIC OR INORGANIC BASES AND PHARMACEUTICAL COMPOSITION SHOWING INHIBITING ACTIVITY WITH RELATION TO NEUROTENSINE

AMIDOPYRAZOLE DERIVATIVES OR THEIR SALTS WITH ORGANIC OR MINERAL ACIDS OR WITH ORGANIC OR INORGANIC BASES AND PHARMACEUTICAL COMPOSITION SHOWING INHIBITING ACTIVITY WITH RELATION TO NEUROTENSINE

机译:酰胺吡唑衍生物或它们的盐与有机或矿物酸或与有机或无机碱和药物组合物的显示抑制活性与神经氨酸有关

摘要

FIELD: organic chemistry, pharmacy. SUBSTANCE: products: derivatives of amidopyrazole of the general formula (I) where Pyr means the group of formulas or where R1 - phenyl substituted with definite substituents; R1a - benzyl-group possibly substituted with Hal; RIV - H, Hal. (C1-C6)-alkyl; RV - phenyl-group substituted with definite substituents, or RV - naphthyl, pyridine or styrene substituted with (C1-C4)-alkyl, or RIV and RV taken together mean the group -2Ph-(CH2)i where phenyl-group substitutes pyrazole at 5 position and group (CH2)i where i = 1-3 substitutes pyrazole at position 4; R-H1(C1-C4)-alkyl; Z - -OH1(C1-C6)-alkoxy, amino; X and X1 - H or one of these is H and another is (C1-C6)-alkyl, (C3-C6)-cycloalkyl-(C1-C4)-alkyl, acetamido-(C1-C4)-alkylthiomethyl, guanidino-(C1-C4)-alkyl, carboxy-(C1-C4)-alkyl, nitroguanidino-(C1-C4)-alkyl, (C3-C7)-cycloalkyl, phenyl-(C1-C4)-alkyl possibly substituted with Hal, OH; heteroaryl-(C1-C4)-alkyl where heteroaryl - imidazolyl or indolyl, or X is H and X1 and R taken together form with nitrogen atoms the cycle of the formula (II) where m = 1-2, or indolinyl cycle, or 4,5,6,7-tetrahydro-[2,3-c]-thienopyridine cycle, or X and X1 where each means (C1-C4)-alkyl-(C3-C6)-cycloalkyl or phenyl, or X and X1 together with carbon atom form (C3-C12)-cycloalkylidene group that is substituted if necessary with (C1-C3)-alkyl, adamantylene, quinuclidinylidene, 4-piperidinylidene group which is possibly substituted with N-benzyl, tetrahydronaphthylidene, 4-tetrahydropyranyliedene, dihydro-2,3(4H)-4-benzothiopyranylidene, or dihydro-(4H)-4-benzopyranylidene group, or the group of the formulas a () and b (), or their salts with acids or bases and pharmaceutical composition based on the indicated compounds. ???EFFECT: improved method of synthesis.
机译:领域:有机化学,药学。物质:产品:通式(I)的氨基吡唑的衍生物,其中Pyr表示该基团的公式其中R 1 -被确定的取代基取代的苯基; R 1a -可能被Hal取代的苄基; R IV -H,Hal。 (C 1 -C 6 )-烷基; R V -被确定的取代基取代的苯基,或R V -被(C 1 -C 4 )-烷基或R IV 和R V 表示基团-2Ph-(CH 2 )< Sub> i ,其中苯基在5位上取代吡唑,而基团(CH 2 i ,其中i = 1-3,在4位上取代吡唑; R-H 1 (C 1 -C 4 )-烷基; Z--OH 1 (C 1 -C 6 )-烷氧基,氨基; X和X 1 -H或其中一个为H,另一个为(C 1 -C 6 )-烷基,(C 3 -C 6 )-环烷基-(C 1 -C 4 )-烷基,乙酰胺基-(C 1 -C 4 )-烷硫基甲基,胍基-(C 1 -C 4 )-烷基,羧基-(C 1 -C 4 )-烷基,硝基胍基-(C 1 -C 4 )-烷基,(C 3 -C 7 )-环烷基,苯基-(C 1 -C 4 )-烷基可能被取代哈尔,俄亥俄州;杂芳基-(C 1 -C 4 )-烷基,其中杂芳基-咪唑基或吲哚基,或X为H,X 1 和R一起与氮原子形成的式(II)的循环其中m = 1-2,或吲哚啉环,或4,5,6,7-四氢-[2,3-c]-噻吩并吡啶环,或X和X 1 ,其中每个表示(C 1 -C 4 )-烷基-(C 3 -C 6 )-环烷基或苯基,或X和X 1 < / Sup>与碳原子形成(C 3 -C 12 )-亚环烷基,必要时可被(C 1 -C 3 )-烷基,金刚烷,奎宁环亚叉基,4-哌啶亚基,可能被N-苄基,四氢萘叉基,4-四氢吡喃二烯,二氢-2,3(4H)-4-苯甲硫基吡喃基或二氢取代-(4H)-4-苯并吡喃基,或公式中的组()和b(<图像文件=” 00000012.GIF“ he =” 18“ imgContent =” undefined“ imgFormat =” GIF“ wi =” 24“ />)或它们与酸或碱形成的盐以及根据所示化合物的药物组合物。效果:改进的合成方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号